Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diling Weitong Granules
- Development stage
- Unknown
- Lead developer
- Sinopharm Holding
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Diling Weitong Granules is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Jiangsu Pharmaceutical Co., Ltd., a company associated with the Yangtze River Pharmaceutical Group. It is specifically indicated for the treatment of epigastric pain attributed to qi stagnation according to TCM diagnostic principles. As a multi-herb granule formulation, it is designed to work through the synergistic effects of its constituent herbal components to provide symptom relief for stomach pain and discomfort. The product is an approved pharmaceutical in China and is administered orally as granules.
- Brand names
- Diling Weitong Granules
- Other names
- Diling Weitong
Beyond the preview
Go deeper on Diling Weitong Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diling Weitong Granules.